SAN FRANCISCO, CA, Oct 6, 2015 –  Cloudious9®, a next generation developer and manufacturer of vaporizer products announced today the upcoming Hydra 9, the world’s first consumer vaporizer product with a built-in water filtration system. With an aluminum alloy cylinder frame and borosilicate glass, the Hydra 9 is not only functional and durable but is designed to fit modern life style needs and pace, which incorporates patent pending technologies that makes vaporizing experiences more efficient than ever before. This device provides its users with an exceptional burning or vaporizing experience, in a well thought over, state of the art product.

Cloudious9’s CEO, Richard Huang said, “There are so many features missing and inconveniences in today’s vaporizers. We addressed some of the pressing issues while adding features never before explored by the vaporizer community in our Hydra 9 design. We’re confident this is the beginning of a series of innovations we can bring to this community.”

Hydra 9™ teaser video: Click Here

PRODUCT FEATURES
Hydra 9, first device with integrated water filtration that burns or vaporizes, incorporates unique features:

• It comes in a portable, convenient size, easy to fill with water. It is completely anti-leak from top to bottom; it makes it possible to carry or ride a bike with it, or shake without worrying
• 1 button and multiple temperature settings
• Made of anti-rust space-craft grade aluminum alloy, borosilicate glass body and has a cutting edge water filtration system.
• Removable air duct and anti-leak valve for ease of cleaning and maintenance
• Borosilicate glass twist-on wide-mouth mouthpiece.
• Interchangeable Vaporization and Burning attachment to easily switch between the 2 methods; easy to maintain and cost friendly to replace.
• Two attachments for different purposes: *
  • 1) Vaporization:
    Large porcelain vaporization chamber attachment 1.5cm in diameter and 1.5cm deep. Patent pending built-in heat distribution mechanism.
  • 2) Burning: Burning attachment where the heat source is derived from a vertical heating element which allows heat to distribute more evenly from inside out, patent pending. It has dual-air dock during burning, to allow users to increase or decrease airflow intake.

*More attachments could be developed as future add-ons.

Pre-sale date has yet to be determined, but Cloudious9 encourages consumers to sign-up on www.cloudious9.com to receive a notification of the pre-sale date and a pre-sale discount code.

About Cloudious9
Located in the heart of The Silicon Valley, Cloudious9 is an organization utilizing cutting-edge technology and world-class talent to produce exceptional products that promises to deliver the ultimate user experience. Our primary vision is to ensure every product designed is groundbreaking and to constantly maintain a culture where innovation is valued above all else.

** News and content distribution provided by 1800pr.com

NORCROSS, GA, Oct 6, 2015 – Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that Executive Chairman Jim Czirr will be interviewed on “The Big Biz Show” hosted by Bob “Sully” Sullivan. In this exclusive interview, Mr. Czirr will discuss Galectin Therapeutics’ progress developing a treatment for the silent epidemic Fatty Liver disease and advanced liver fibrosis and cirrhosis. Listeners will also hear about results that occurred in the most recent clinical trials.

Date: Tuesday, October 6, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: Syndicated: AFN, TiVo, CBS Radio, Fox Business, AOL, YouTube, Biz Talk Radio, Clear Channel
Show: The Big Biz Show
Host: Bob “Sully” Sullivan
TV Stream: http://www.ustream.tv/biztv

About The Big Biz Show
The Big Biz Show is a nationally syndicated radio / television program broadcast on 150 stations throughout the country with a weekly reach of 1.7 million listeners reaching over 70 million homes. The Emmy Award-winning show was named by TALKERS Magazine as one of the “Top 10 Most Influential Financial Shows” in the country, and is highly recognized for discussing current business events, internet related issues, and other hot topics in the business world, doing so in an informing, laid back, and humorous manner. Hosts, Bob “Sully” Sullivan and Russ “T Nailz” Stolnack, both are renowned and experienced radio broadcast personalities. The Big Biz Show airs Tuesday through Friday, 12:00 p.m. to 1:00 p.m. PT.

About Jim Czirr
Jim Czirr is the Executive Chairman of Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer. Mr. Czirr is a co-founder of 10X Fund, L.P. and is a managing member of 10X Capital Management LLC, the general partner of 10X Fund, L.P. Mr. Czirr was a co-founder of Galectin Therapeutics in July 2000. Mr. Czirr was instrumental in the early stage development of Safe Science Inc., a developer of anticancer drugs. He served from 2005 to 2008 as Chief Executive Officer of Minerva Biotechnologies Corporation, a developer of nano particle bio chips to determine the cause of solid tumors, and was a consultant to Metalline Mining Company Inc., now known as Silver Bull Resources, Inc., (OTCQB: SVBL), a mineral exploration company seeking to become a low cost producer of zinc. Mr. Czirr received a B.B.A. degree from the University of Michigan.

About Galectin Therapeutics, Inc.
Galectin Therapeutics (NASDAQ: GALT), is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources. Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy. To learn more about Galectin Therapeutics please visit us at http://galectintherapeutics.com

WEXFORD, PA, Oct 6, 2015 – InteloMed, Inc., a leading developer of non-invasive cardiovascular monitoring systems, announced today that CEO Jill Schiaparelli will guest host a special edition of HealthTechTalk Live Radio Show at the UBM MedTech World Medical Design and Manufacturing (MD&M) conference in Philadelphia on October 7^th and 8^th, 2015.

Live on location from MD&M Philadelphia, the four-state region’s largest medtech event, HealthTechTalk Live will interview some of the most high-profile, innovative industry and academic leaders presenting at the conference.

Serving a broad community of medtech professionals, MD&M Philadelphia delves into the latest challenges and opportunities that are impacting the industry. A multi-track conference program explores design innovations, 3D printing, new materials, packaging design and more.

About UBM Canon
UBM Canon is the leading B-to-B event producer, publisher, and digital media company for the world’s $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. UBM Canon is part of UBM plc (UBM.L), a global provider of media and information services for professional B-to-B communities and markets.

About HealthTechTalk Live Radio Show
HealthTechTalk Live Show broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm every Saturday. Guest host Jill Schiaparelli interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTechTalk Live, http://www.healthtechtalk.com/.

About InteloMed
InteloMed is redefining the standard of care in intelligent cardiovascular monitoring in hospitals and health care facilities through its non-invasive CVInsight™ Platform. The CVInsight™ Platform provides real-time insights on the stress level of the cardiovascular system to inform clinical decisions which, as part of a well-managed care plan, may lead to earlier detection of cardiovascular decline, earlier intervention, decreased hospitalization and improved patient outcomes. The CVInsight™ Platform has functionality in hospital and outpatient settings and has clinical applications in multiple areas including hemodialysis, heart failure, and the surgical continuum. InteloMed is headquartered in Wexford, PA. For more information, visit us at www.InteloMed.com.

Safe Harbor Statement
Certain statements in this release are “forward-looking” and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.

NEW YORK, NY, Oct 6, 2015 – One week after the Sustainable Development Goals were officially adopted by the United Nations General Assembly, creative media leaders gathered at a panel during Advertising Week to discuss the implementation of The World’s Most Important Campaign to be launched in January.

The World’s Most Important Campaign is a 15-year global communications strategy focused on creating a unified brand for the Sustainable Development Goals (SDGs) and inspiring global citizens to take action to achieve success.

Moderator Jason Harris, President & CEO of the creative advertising agency Mekanism, led the panel. Panelists included Communications Director and Spokesperson for the President of the United Nations General Assembly, 70^th session Dan Thomas, Co-Founder & Chairman of PVBLIC Foundation, Sergio Fernández de Córdova, Founder & CCO of Tröllback + Company, Jakob Tröllback, and Founder of the People + Planet Project, Natalia Vega-Berry.

Dan Thomas represented the United Nations perspective on the panel and spoke about the development of the goals and the process behind having them approved by all 193 member countries. Thomas stressed that the UN has recognized the importance of public-private partnerships especially in terms of spreading the message of the goals and is hopeful about the future of The World’s Most Important Campaign‘s implementation.

Jakob Tröllback discussed his involvement in the development of icons that will be used as universal images that support the SDGs brand. The images are simple and their meaning translates across all global audiences.

PVBLIC Foundation has helped identify various influential partners that can help amplify the messages behind the SDGs. Sergio Fernández de Córdova explained, “When [PVBLIC] started working with the UN Office for Partnerships last year, we asked ourselves how do we take this global?” PVBLIC has since gathered commitments from over 170 organizations that want to help promote and achieve the SDGs over the next 15 years and will continue to facilitate these partnerships.

Natalia Vega-Berry discussed the importance of creating action networks that will allow people to get involved. Vega-Berry’s People + Planet Project provides a platform for global citizens to engage in discussion on how to create social change related to the SDGs
The World’s Most Important Campaign will have its official launch in January 2016. Mekanism is currently working as the creative leader behind the campaign’s advertising efforts.

The panel helped initiate discussion and awareness to the public and advertising industry about the future efforts. In order for the goals to be accomplished, global participation is necessary.

Tröllback concluded the panel with a motivating final remark stating, “Let’s do something that will make the aliens proud.”

Check out the entire panel discussion on Advertising Week’s website.

Get involved with The World’s Most Important Campaign at bit.ly/TheMICWeb

About PVBLIC Foundation
PVBLIC Foundation is an in-kind grant making organization that harnesses the power of media assets to drive social change. Through partnerships with leading media companies, PVBLIC works strategically to pair media assets with key non- profits. We utilize existing and emerging technologies to increase issue awareness around important causes and to help non-profits amplify their message. @PVBLICF or visit www.pvblic.org

About Mekanism
Mekanism is an award-winning full service creative agency based with offices in San Francisco, New York and Chicago. Mekanism works closely with brands to create shareable and provocative campaigns that engage audiences. The agency was named as a 2015 Ad Age A-List Standout, and has been profiled by the New York Times, Fast Company and ABC’s “Nightline,” and their unique structure has been covered and studied by Harvard Business School.

About Tröllback + Company
Trollbäck + Company is an award-winning creative studio communicating engaging ideas in the simplest, smartest and most visionary ways. Led by executive creative director Jakob Trollbäck, the collaborative group directs television commercials, designs opening titles, brands networks and creates experience-based content for global brands. Trollbäck + Company is the recipient of numerous awards including a primetime Emmy, and is regularly featured in publications and exhibits around the world. http://www.trollback.com

About the People+Planet Project
The People+Planet Project (P+PP) is an action network for social good created to help the world achieve the Sustainable Development Goals. The first phase of the P+PP platform will launch January 1, 2016, to support these shared objectives over the next 15 years. The platform will aggregate content, tools and calls to action to engage a global community of individuals, businesses, NGOs and other organizations as they shift their lifestyles and business models to be more sustainable. Exclusive P+PP Campaigns will launch within the platform to engage different audiences around the economic, social and environmental foundations of sustainable development; the first P+PP Campaign will launch in early 2016. The P+PP is an initiative of The Global Brain, a creative-innovation agency headquartered in Boulder, CO. Find more information and sign up to join the community at peopleplanetproject.org.

** News and content distribution provided by 1800pr.com

NEW YORK, NY, Oct 2, 2015 – Days after the United Nations General Assembly adopts the new Sustainable Development Goals (SDGs), a new post-2015 initiative to support these universal objectives was introduced at an event in the UN Visitors Plaza “We the Peoples Hub.”

The People+Planet Project (P+PP), an initiative from The Global Brain Foundation and PVBLIC Foundation, is a new action network for social good created to support the SDGs over the next 15 years. On September 29, the P+PP was unveiled to the public at an event called “Transforming the Future for People and Planet.”

Ms. Amina J. Mohammed, the UN Secretary-General’s Special Adviser on Post-2015 Development Planning, appeared at the event to speak about the SDGs and the P+PP.

“What you’ve had to show us is amazing,” said Ms. Mohammed to Vega-Berry in regard to the P+PP’s development. “[The] People+Planet [Project] is about connecting communities, solutions, and challenges to try to make [the goals] real over time. We’ve got 15 years; a 15-mile hike.”

Founder of The Global Brain and the P+PP Natalia Vega-Berry created the P+PP platform to empower a community of individuals, businesses, nonprofits, NGOs, and organizations to consume consciously, profit responsibly and live purposefully to achieve the SDGs.

“This is a great opportunity for the global community, as we are just beginning to understand the possibilities we can create for the future,” said Vega-Berry. “People are demanding change. We want more sustainable and inclusive business models. We must be disruptive and bold as we work together to change the world’s ecosystem and achieve the SDGs.”

Chairman and Co-Founder of PVBLIC Foundation Sergio Fernandez de Cordova stated: “We highly value our partnership with P+PP as it highlights the imperative need for reciprocal and transparent partnerships in order to accomplish the SDGs.”

“We welcome the involvement of Amina J. Mohammed, the UN Secretary-General’s Special Adviser on Post-2015 Development Planning, Christina Gallach, the United Nations Under-Secretary-General for Communications and Public Information, and Dan Thomas, Communications Director and Spokesperson for the President of the United Nations General Assembly, 70^th Session in launching P+PP,” said Mr. Fernandez de Cordova, “as it reinforces the commitment to the underlying mission of #SDG 17, which emphasizes that it is through partnerships that success will be made possible. Each of the goals are interconnected and we must work together in order to create impact.”

During the event, Theo Cosmora, the founder and CEO of SocialEco, shared a surprise presentation of the SDG Games with the event’s attendees, a new initiative in collaboration with the P+PP and PVBLIC Foundation that aims to create awareness around the SDGs through engaging, educational games.

“We developed the world’s first SDG games, beginning with two games, SDG1 and SDG3, that focus on the first and third of the SDG, poverty and health, respectively,” said Cosmora. “The SDG Games will help creative global awareness of the SDGs and their objectives through simple, educational mobile games. Increased awareness and education on the goals via fun and competitive mobile games will accelerate their achievement.”

SocialEco is dedicated to empower a cutting edge and holistic Social Economy Ecosystem that empowers people, builds business, and supports the planet.

Jules Schroeder, founder of CreateU and an early collaborator with the P+PP, told the event’s attendees about her new online platform to reimagine higher education.

“CreateU’s focus is to educate our youth with relevant skills, like how to share ideas, network with peers, and become conscious consumers, so the next generation has the resources needed to reshape our planet,” said Shroeder. “Education is the starting block for transformation and upgrading the current global system to help us accomplish these goals.”

Launching its first phase January 1, 2016, the P+PP platform will support the global community’s necessary shift to more sustainable lifestyles and business models. The P+PP will provide content, tools, and calls to action to facilitate this transformation and help make the SDGs a mainstream priority until 2030.

The Global Brain is a creative-innovation agency headquartered in Boulder, CO, that works collectively to promote causes, organizations, and brands that support a sustainable future.

The first two SDG Games created by SocialEco, SDG1 and SDG3, are available to download now from the Android Play Store. IOS versions of the games are due to be launched on the Apple App store in October 2015. SocialEco has developed four other games and are refining them to launch a minimum of 10 SDG Games to cover the main SDGs sectors. Find more information about the SDG Games at http://sdggames.com/ and download SDG1 and SDG3 at https://play.google.com/store/apps/details?id=com.socialeco.sdg1 and https://play.google.com/store/apps/details?id=com.socialeco.sdg3&hl=en.

About the People+Planet Project
The People+Planet Project (P+PP) is an action network for social good created to help the world achieve the Sustainable Development Goals. The first phase of the P+PP platform will launch January 1, 2016, to support these shared objectives over the next 15 years. The platform will aggregate content, tools and calls to action to engage a global community of individuals, businesses, NGOs and other organizations as they shift their lifestyles and business models to be more sustainable. Exclusive P+PP Campaigns will launch within the platform to engage different audiences around the economic, social and environmental foundations of sustainable development; the first P+PP Campaign will launch in early 2016. The P+PP is an initiative of The Global Brain, a creative-innovation agency headquartered in Boulder, CO. Find more information and sign up to join the community at peopleplanetproject.org.

About PVBLIC Foundation:
PVBLIC Foundation is an in-kind grant making organization that harnesses the power of media assets to drive social change. Through partnerships with leading media companies, PVBLIC works strategically to pair media assets with key non- profits. We utilize existing and emerging technologies to increase issue awareness around important causes and to help non-profits amplify their message. PVBLIC is an early partner of the P+PP and was the event’s media sponsor. @PVBLICF or visit http://www.pvblic.org

** News and content distribution provided by 1800pr.com

NEW YORK, NY, Sep 29, 2015 – Jacquii LLC, a successful marketer of a highly unique breath freshener product, Eatwhatever, that assures confident kissable breath from within in two quick steps — simply swallow a tiny gel and suck on a mint — announced today that President Jacqui Rosshandler will be interviewed on “The Big Biz Show” hosted by Bob “Sully” Sullivan. In this exclusive interview, Ms. Rosshandler will discuss the launch of their exciting new product WoofMints, a revolutionary natural breath product for dogs (canines) due in stores late 2015.

Date: Tuesday, September 29, 2015
Start Time: 3:35pm ET | 12:35pm PT | 2:35pm CT (U.S.) (Approx.)
Network: Syndicated: AFN, TiVo, CBS Radio, Fox Business, AOL, YouTube, Biz Talk Radio, Clear Channel
Show: The Big Biz Show
Host: Bob “Sully” Sullivan
TV Stream: http://www.ustream.tv/biztv

About The Big Biz Show
The Big Biz Show is a nationally syndicated radio / television program broadcast on 150 stations throughout the country with a weekly reach of 1.7 million listeners reaching over 70 million homes. The Emmy Award winning show was named by TALKERS Magazine as one of the “Top 10 Most Influential Financial Shows” in the country, and is highly recognized for discussing current business events, internet related issues, and other hot topics in the business world, doing so in an informing, laid back, and humorous manner. Hosts, Bob “Sully” Sullivan and Russ “T Nailz” Stolnack, both are renowned and experienced radio broadcast personalities. The Big Biz Show airs Tuesday through Friday, 12:00 p.m. to 1:00 p.m. PT.

About Jacqui Rosshandler
Jacqui Rosshandler, an Aussie turned New Yorker, is the president and COO of Jacquii LLC. A business dynamo, Jacqui said, “My first dream was to create a revolutionary product delivering kissable breath essentially from within where odorous food goes in the first place. I’m living that dream now with Eatwhatever, soon to be joined by WoofMints, a product created for the pet market providing more sociable breath for dogs (canines); ‘excited’ about the launch is an understatement.”

About Jacquii LLC
Founded as Jacquean Products LLC in 2008, the company began selling a boutique version of the product Eatwhatever in niche stores like Colette (Paris), Zitomer, C.O, Bigelow and Ricky’s (NYC), then on global websites Amazon, Victoria Health, and Shopmasc. Late 2010, Jacqui met Arthur Shorin, former CEO of Topps, a multi-national company famous for products such as Topps baseball cards, Bazooka bubble gum and Ring Pops. Arthur “got” Eatwhatever instantly, and a new growth chapter began as Jacquii LLC. Today, Eatwhatever is on counters in fine stores across the US such as Duane Reade, Whole Foods, Fairways, Fresh Markets, Dylan’s Candy, Earth Fare and many more. The company eagerly anticipates its WoofMints launch and hopes that with both products eventually everyone (two AND four legged) can eat whatever (including onion and garlic!) and feel confident and kissable.

IRVINE, CA, Sep 29, 2015 – NuGene International, Inc. (“NuGene”) (OTCQB: NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, was recently featured in a study and presentation by Dr. Dendy Engelman, a NuGene Advisory Board member and Director of Dermatological Surgery at New York Medical College. The presentation of the results occurred at the 6th Five-Continent Congress on Lasers and Aesthetic Medicine held September 3-6 in Cannes, France.

Dr. Engelman’s presentation titled, Potent Human Adipose Derived Stem Cell Treatments Revolutionizing Topical Anti-Aging Therapy, described a limited study performed to assess the efficacy of NuGene’s Light and Bright Gel in improving the appearance of skin pigmentation. In the study, blinded investigators observed an improvement in skin pigmentation appearance with all patients where:

• 33% of patients experienced a 50% improvement in skin appearance
• 56% of patients experienced a 75% improvement in skin appearance

The subjects of the study were females between the ages of 30 to 60 years old, with hyperpigmentation on the face with moderate severity. The products used in the study featured NuGene’s unique stem cell based technology employing a high concentration of bioactive molecules from stem cell culture media derived from human adipose stem cells.

In the study, the information was collected by an independent investigator who was provided with photographic evidence showing before and after images of the participants and concluded that there was significant improvement in the lack of the appearance of aging. Images of participants before and after the use of the product can be viewed here.

“NuGene’s Light and Bright Gel provides an innovative approach to skin and hair rejuvenation. Clinical findings from topical application of NuGene’s product yielded results, in my opinion, previously only attainable by in-office procedures. I have been overwhelmed by the efficacy of this product and am thrilled to offer this product line to my patients,” remarked Dr. Engelman.

“Dr. Engelman presented NuGene’s non-hydroquinone based solution for hyperpigmentation aesthetics to some of the world’s top dermatologists and aestheticians. NuGene has a significant opportunity to impact this expanding market,” said Dr. Saeed Kharazmi, Chairman and co-founder of NuGene. Hydroquinone, a common component of bleaching creams, has already been banned in Japan, the European Union, and Australia due to potential cancer concerns.

According to the Global Industry Analysts, Inc. (GIA), the global market for Skin Lighteners is projected to reach US$23 billion by 2020, driven by the desire among both women and men to have even-toned skin.

About Dr. Dendy Engelman
Dr. Engelman is a board certified dermatologic surgeon and an associate at Manhattan Dermatology & Cosmetic Surgery. She is a fellow of the American Academy of Dermatology, American Society of Dermatologic Surgery and American College of Mohs Surgery (a procedure that removes skin cancer under local anesthetic). Most recently, Dr. Engelman was appointed Director of Dermatologic Surgery at New York Medical College where she oversees the training of future Mohs surgeons and dermatologists. Dr. Engelman also serves as a scientific advisory board member of NuGene and consultant to numerous pharmaceutical companies including Genetech, Allergen, Galderma, Merz and L’Oreal.

About NuGene International, Inc.
NuGene International, Inc. specializes in developing, manufacturing and marketing proprietary regenerative cosmeceutical and pharmaceutical products based on adipose derived human stem cell and human stem cell media. The US Department of Health and Human Services calls regenerative medicine the “next evolution of medical treatments.” The regenerative medical market which includes cosmeceuticals and pharmaceuticals was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Service Global Cosmeceuticals Market report. NuGene’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company has four patents pending covering 15 unique applications. NuGene’s goal is to leverage its knowledge and expertise to develop age defying cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.

Forward Looking Statements
This document contains “forward-looking statements: statements related to future, not past, events. In this context, forward-looking statements often address NuGene’s expected future business and financial performance and financial condition, and often contain words such as “expect: “anticipate,” intend,” plan,” “believer,” “seek,” “see,” “will,” “would,” or “target.”

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our current and future sales, planned operations, marketing activities and other operational, sales and financial plans. These may include our ability to convert pre-order commitments/wins into orders; timing of planned and anticipated product deliveries; the price we realize on orders since commitments/wins are stated at list prices; customer actions or developments such as customer returns and other factors that may affect the level of demand and performance of the major industries and customers we serve; the impact of regulation and regulatory, investigative and legal proceedings and legal compliance risks, including the impact of regulation and litigation; adverse market conditions, timing of and ability to obtain required regulatory approvals, or other factors relating to us; the impact of potential information technology or data security breaches; and the other factors. These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements.

NEW YORK, NY, Sep 28, 2015 – Days after the United Nations General Assembly adopts the new Sustainable Development Goals (SDGs), a new post-2015 initiative to support these universal objectives will be introduced at an event in the UN Visitors Plaza “We the Peoples Hub.”

The People+Planet Project (P+PP) is a new action network for social good created to support the SDGs over the next 15 years. Tomorrow, Tuesday, September 29, from 4:00-6:00 pm, the P+PP will be unveiled to the public at an event called “Transforming the Future for People and Planet.”

Ms. Amina J. Mohammed, the UN Secretary-General’s Special Adviser on Post-2015 Development Planning, will appear at the event to speak about the SDGs and the P+PP.

“The People+Planet Project will contribute to mobilization initiatives to achieve the Sustainable Development Goals. We are excited to see organizations like The Global Brain join others to take a stand and support our shared future with projects in service of the planet and its people,” said Ms. Mohammed.

Launching its first phase January 1, 2016, the P+PP platform will support the global community’s necessary shift to more sustainable lifestyles and business models. The P+PP will provide content, tools, and calls to action to facilitate this transformation and help make the SDGs a mainstream priority until 2030.

The P+PP is an initiative from The Global Brain Foundation and the PVBLIC Foundation. Founder of The Global Brain and P+PP Campaign Director Natalia Vega-Berry created the P+PP platform to empower a community of individuals, businesses, nonprofits, NGOs and organizations to consume consciously, profit responsibly, and live purposefully to achieve the SDGs.

“I believe that it’s time for us to be active participants in shaping the solutions to the challenges our world faces,” said Vega-Berry. “Only we can build the future that we want.”

Chairman and Co-Founder of PVBLIC Foundation Sergio Fernandez de Cordova stated, “I am thrilled to be part of the launch of P+PP, a global action initiative, a needed factor in the implementation of the SDGs. At the event we will also make an announcement about PVBLIC’s long term commitment to the project.”

In addition to the aggregated resources on the P+PP, exclusive P+PP Campaigns will launch within the platform to engage different audiences around the economic, social and environmental foundations of sustainable development. These action-oriented, solutions-focused campaigns will help unite the global community to make the SDGs a reality. Only P+PP community members will have access to take part in the campaigns, the first of which will launch in early 2016.

“The People+Planet Project Campaigns are focused on actions, because we want to build a global environment in which sustainable living is commonplace; the campaigns will help move us in that direction,” said Vega-Berry. “I can’t say much about the campaigns at this time, but I can share that the first one will be an economic-focused campaign called ‘Every Dollar’ that will plant the seed of conscious consumerism by nurturing the realization that when we spend and invest our money, we are voting for the world we want to live in now and the world that future generations will be born into.”

Jules Schroeder, founder of CreateU, will be in attendance at the “Transforming the Future for People and Planet” event. CreateU is an online platform designed to reimagine higher education, striving to create an education system in which students are the visionaries of their course of study and ultimately their lives. The P+PP is proud to collaborate with CreateU as it pioneers contemporary education in support of the fourth SDG, to ensure inclusive and equitable quality education and promote lifelong learning opportunities for all. In support of this universal objective, CreateU will provide the worldwide community of students with an education experience unlike any other that is less costly and more current with the evolving world.

Accredited media are welcome to attend (so long as space remains) but must RSVP to Leia Schultz at leia@peopleplanetproject.org with their name, title and organization to be added to the guest list. There will be a short Q&A session during the event. Contact Leia to schedule an interview with P+PP Campaign Director Vega-Berry.

About PVBLIC Foundation, an in-kind grant making organization that harnesses the power of media assets to drive social change, is an early partner of the P+PP and is the event’s media sponsor.

About The Global Brain Foundation is a creative-innovation agency headquartered in Boulder, CO, that works collectively to promote causes, organizations and brands that support a sustainable future.

About the People+Planet Project
The People+Planet Project (P+PP) is an action network for social good created to help the world achieve the Sustainable Development Goals. The first phase of the P+PP platform will launch January 1, 2016, to support these shared objectives over the next 15 years. The platform will aggregate content, tools and calls to action to engage a global community of individuals, businesses, NGOs and other organizations as they shift their lifestyles and business models to be more sustainable. Exclusive P+PP Campaigns will launch within the platform to engage different audiences around the economic, social and environmental foundations of sustainable development; the first P+PP Campaign will launch in early 2016. The P+PP is an initiative of The Global Brain, a creative-innovation agency headquartered in Boulder, CO. Find more information and sign up to join the community at peopleplanetproject.org.

* News and content distribution provided by 1800pr.com

NORTH BETHESDA, MD, Sep 28, 2015 – NextBigThingInvestor.com released an interview by Tobin Smith, CEO of NBT Equities Research and former Contributor/Guest Anchor for Fox News & Fox Business News with Josh Blacher, CFO of Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD).

“During the ‘The Next Big Thing Report’ segment, Mr. Smith refers to Aramchol™ as a potential blockbuster treatment for the growing medical concern of fatty liver disease, including NASH, alongside other metabolic disorders including obesity, high cholesterol, high blood pressure, and adult diabetes. NASH is now estimated to affect about 45 million adults in the US and EU-5 alone,” said Galmed’s CFO, Josh Blacher.

“Aramchol™ is designed to root out the core problem of NASH, excess liver fat. Galmed’s clinical studies to date have demonstrated that Aramchol-treated patients reduced liver fat by 20 percent compared to untreated patients and improved important cardiovascular markers. In its 4 clinical trials to date, Aramchol™ also has not shown observable adverse side effects.”

Mr. Blacher concluded, “With no treatment for NASH patients currently available, our larger Phase IIb clinical trial — the ARREST Study — will test up to 2X higher dosages with hopes of an even better therapeutic effect and similar safety results. Additional exposure from Mr. Smith and the financial community is a key component to our success.”

Mr. Smith commented, “Assuming launch in 2020, recent published equity research indicates up to $3 billion a year peak market sales for Aramchol by 2024.”

Mr. Smith noted, “The underreported worldwide NASH liver disease epidemic is highly correlated to other metabolic-related disorders that continue to grow at alarming rates, such as elevated levels of LDL cholesterol and Type 2 diabetes worldwide. Without an effective treatment, the end-stage outlook for NASH patients is an increased risk of a life-threatening cardiovascular event (heart attack or stroke) or eventually liver transplantation, which is not only prohibitively expensive but impractical given transplantable liver availability.”

The two part video interview with Tobin Smith can be accessed on the following links:
Part I: https://nbtequitygroup.wistia.com/medias/tmp49znkx3
Part II: https://nbtequitygroup.wistia.com/medias/32qbqxwatw

NextBigThingInvestor.com is a division of Velocity Studio LLC focused on transformational growth industries and companies. The company was founded by well-known equities research analyst Tobin Smith, a former contributing market analyst (2000-2013) for Fox News Channel and a regular panelist on its highly rated “Bulls & Bears” weekly business program. Mr. Smith is the Editor-in-Chief of NBT Investor Pro, an investment newsletter advisory focused on investments in transformational change.

About Galmed Pharmaceuticals, Ltd.
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of liver diseases. It is developing Aramchol, which is in Phase IIb clinical trial for the treatment of non-alcoholic steato-hepatitis in patients who also suffer from obesity and insulin resistance. The company was founded in 2000 and is headquartered in Tel Aviv, Israel.

More information about Galmed Pharmaceuticals can be found at http://galmedpharma.com.